Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 893 Thousand USD | -70.12% |
| 2022 | 2.98 Million USD | 105.57% |
| 2021 | 1.45 Million USD | 116.69% |
| 2020 | 671 Thousand USD | -19.64% |
| 2019 | 835 Thousand USD | 5.43% |
| 2018 | 792 Thousand USD | -3.41% |
| 2017 | 820 Thousand USD | 0.0% |
| 2016 | 820 Thousand USD | -31.72% |
| 2015 | 1.2 Million USD | -3.07% |
| 2014 | 1.23 Million USD | -11.25% |
| 2013 | 1.39 Million USD | 57.38% |
| 2012 | 887 Thousand USD | 29.87% |
| 2011 | 683 Thousand USD | -6.69% |
| 2010 | 732 Thousand USD | -23.91% |
| 2009 | 962 Thousand USD | 73.65% |
| 2008 | 554 Thousand USD | 81.05% |
| 2007 | 306 Thousand USD | -9.73% |
| 2006 | 339 Thousand USD | -67.68% |
| 2005 | 1.04 Million USD | 90.38% |
| 2004 | 551 Thousand USD | -25.54% |
| 2003 | 740 Thousand USD | -30.52% |
| 2002 | 1.06 Million USD | -27.6% |
| 2001 | 1.47 Million USD | 30.99% |
| 2000 | 1.12 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 666 Thousand USD | -25.42% |
| 2023 Q2 | 1.7 Million USD | -33.52% |
| 2023 Q3 | 1.13 Million USD | -33.63% |
| 2023 Q1 | 2.56 Million USD | -14.25% |
| 2023 FY | 893 Thousand USD | -70.12% |
| 2023 Q4 | 893 Thousand USD | -21.04% |
| 2022 Q3 | 3.5 Million USD | 8.66% |
| 2022 Q4 | 2.98 Million USD | -14.65% |
| 2022 Q1 | 2.66 Million USD | 83.01% |
| 2022 Q2 | 3.22 Million USD | 21.12% |
| 2022 FY | 2.98 Million USD | 105.57% |
| 2021 FY | 1.45 Million USD | 116.69% |
| 2021 Q2 | 742 Thousand USD | -0.27% |
| 2021 Q3 | 1.19 Million USD | 61.59% |
| 2021 Q4 | 1.45 Million USD | 21.27% |
| 2021 Q1 | 744 Thousand USD | 0.0% |
| 2020 FY | 671 Thousand USD | -19.64% |
| 2019 FY | 835 Thousand USD | 5.43% |
| 2018 FY | 792 Thousand USD | -3.41% |
| 2018 Q1 | 730 Thousand USD | 0.0% |
| 2018 Q2 | 816 Thousand USD | 11.78% |
| 2017 Q3 | 736 Thousand USD | -10.24% |
| 2017 Q1 | 839 Thousand USD | 2.32% |
| 2017 Q2 | 820 Thousand USD | -2.26% |
| 2017 FY | 820 Thousand USD | 0.0% |
| 2016 Q3 | 1.03 Million USD | -19.92% |
| 2016 Q1 | 1.25 Million USD | 4.16% |
| 2016 Q4 | 820 Thousand USD | -20.62% |
| 2016 FY | 820 Thousand USD | -31.72% |
| 2016 Q2 | 1.29 Million USD | 3.12% |
| 2015 Q2 | 1.39 Million USD | 10.35% |
| 2015 Q3 | 1.34 Million USD | -3.79% |
| 2015 Q4 | 1.2 Million USD | -10.64% |
| 2015 Q1 | 1.26 Million USD | 2.18% |
| 2015 FY | 1.2 Million USD | -3.07% |
| 2014 Q3 | 1.61 Million USD | 4.81% |
| 2014 Q2 | 1.53 Million USD | 5.06% |
| 2014 Q1 | 1.46 Million USD | 4.8% |
| 2014 Q4 | 1.23 Million USD | -23.09% |
| 2014 FY | 1.23 Million USD | -11.25% |
| 2013 Q4 | 1.39 Million USD | -4.84% |
| 2013 FY | 1.39 Million USD | 57.38% |
| 2013 Q2 | 1.14 Million USD | 9.76% |
| 2013 Q3 | 1.46 Million USD | 27.9% |
| 2013 Q1 | 1.04 Million USD | 17.81% |
| 2012 Q2 | 893 Thousand USD | 17.04% |
| 2012 Q3 | 942 Thousand USD | 5.49% |
| 2012 FY | 887 Thousand USD | 29.87% |
| 2012 Q4 | 887 Thousand USD | -5.84% |
| 2012 Q1 | 763 Thousand USD | 11.71% |
| 2011 Q3 | 647 Thousand USD | -6.64% |
| 2011 Q1 | 831 Thousand USD | 13.52% |
| 2011 Q4 | 683 Thousand USD | 5.56% |
| 2011 FY | 683 Thousand USD | -6.69% |
| 2011 Q2 | 693 Thousand USD | -16.61% |
| 2010 Q2 | 882 Thousand USD | -10.55% |
| 2010 Q3 | 1.03 Million USD | 17.12% |
| 2010 Q4 | 732 Thousand USD | -29.14% |
| 2010 FY | 732 Thousand USD | -23.91% |
| 2010 Q1 | 986 Thousand USD | 2.49% |
| 2009 Q2 | 824 Thousand USD | 11.05% |
| 2009 FY | 962 Thousand USD | 73.65% |
| 2009 Q1 | 742 Thousand USD | 33.94% |
| 2009 Q4 | 962 Thousand USD | 7.73% |
| 2009 Q3 | 893 Thousand USD | 8.37% |
| 2008 Q4 | 554 Thousand USD | 13.76% |
| 2008 FY | 554 Thousand USD | 81.05% |
| 2008 Q1 | 312 Thousand USD | 1.96% |
| 2008 Q2 | 313 Thousand USD | 0.32% |
| 2008 Q3 | 487 Thousand USD | 55.59% |
| 2007 Q3 | 371 Thousand USD | 1.09% |
| 2007 Q1 | 408 Thousand USD | 20.35% |
| 2007 FY | 306 Thousand USD | -9.73% |
| 2007 Q2 | 367 Thousand USD | -10.05% |
| 2007 Q4 | 306 Thousand USD | -17.52% |
| 2006 Q3 | 880 Thousand USD | -7.07% |
| 2006 FY | 339 Thousand USD | -67.68% |
| 2006 Q4 | 339 Thousand USD | -61.48% |
| 2006 Q1 | 1.01 Million USD | -3.72% |
| 2006 Q2 | 947 Thousand USD | -6.24% |
| 2005 Q1 | 775 Thousand USD | 40.65% |
| 2005 Q2 | 692 Thousand USD | -10.71% |
| 2005 FY | 1.04 Million USD | 90.38% |
| 2005 Q4 | 1.04 Million USD | -15.88% |
| 2005 Q3 | 1.24 Million USD | 80.2% |
| 2004 FY | 551 Thousand USD | -25.54% |
| 2004 Q4 | 551 Thousand USD | -35.33% |
| 2004 Q3 | 852 Thousand USD | -8.49% |
| 2004 Q2 | 931 Thousand USD | 17.11% |
| 2004 Q1 | 795 Thousand USD | 7.43% |
| 2003 Q4 | 740 Thousand USD | -13.85% |
| 2003 FY | 740 Thousand USD | -30.52% |
| 2003 Q1 | 1.42 Million USD | 33.9% |
| 2003 Q3 | 859 Thousand USD | 14.53% |
| 2003 Q2 | 750 Thousand USD | -47.41% |
| 2002 FY | 1.06 Million USD | -27.6% |
| 2002 Q1 | 1.13 Million USD | -22.91% |
| 2002 Q2 | 1.35 Million USD | 19.84% |
| 2002 Q4 | 1.06 Million USD | -19.2% |
| 2002 Q3 | 1.31 Million USD | -3.02% |
| 2001 Q3 | 1.22 Million USD | 10.31% |
| 2001 Q4 | 1.47 Million USD | 20.57% |
| 2001 FY | 1.47 Million USD | 30.99% |
| 2001 Q2 | 1.1 Million USD | -25.47% |
| 2001 Q1 | 1.48 Million USD | 0.0% |
| 2000 FY | 1.12 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Achiko AG | 1.91 Million USD | 53.354% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 15.16 Million USD | 94.111% |
| Cannabis Sativa, Inc. | 2.02 Million USD | 55.804% |
| CompuMed, Inc. | 4.43 Million USD | 79.875% |
| CompuGroup Medical SE & Co. KGaA | 2.19 Billion USD | 99.959% |
| Cogstate Limited | 57.83 Million USD | 98.456% |
| CareView Communications, Inc. | 4.26 Million USD | 79.049% |
| Craneware plc | 543.65 Million USD | 99.836% |
| Caduceus Software Systems Corp. | 11.9 Million USD | 92.497% |
| Certive Solutions Inc. | 477.94 Thousand USD | -86.841% |
| Drug Free Solution, Inc. | 52.5 Thousand USD | -1600.726% |
| DATATRAK International, Inc. | 4.32 Million USD | 79.337% |
| Strainsforpains, Inc. | 1.57 Million USD | 43.176% |
| Healixa Inc. | 624.97 Thousand USD | -42.887% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 25.52 Million USD | 96.501% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 729.32 Thousand USD | -22.442% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 0.07 USD | -1275714185.714% |
| iCoreConnect Inc. | 15.68 Million USD | 94.307% |
| IQ-AI Limited | 917.49 Thousand USD | 2.67% |
| Cannabiz Mobile, Inc. | 137.8 Thousand USD | -548.003% |
| Mednow Inc. | 14.16 Million USD | 93.695% |
| Galileo Life Sciences, Inc. | 58.41 Thousand USD | -1428.691% |
| MediXall Group, Inc. | 862.01 Thousand USD | -3.595% |
| Mitesco, Inc. | 2838.00 USD | -31365.821% |
| MobileSmith, Inc. | 1.04 Million USD | 14.864% |
| NantHealth, Inc. | 159.55 Million USD | 99.44% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 1.88 Million USD | 52.65% |
| Patient Access Solutions, Inc. | 489.19 Thousand USD | -82.546% |
| Pharma-Bio Serv, Inc. | 19.9 Million USD | 95.513% |
| PPJ Healthcare Enterprises, Inc. | 19.01 Million USD | 95.303% |
| Medical Cannabis Payment Solutions, Inc. | 38.23 Thousand USD | -2235.373% |
| Renalytix Plc | 7.97 Million USD | 88.798% |
| Revium Recovery Inc. | 5.63 Million USD | 84.139% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 3.81 Million USD | 76.615% |
| Vaso Corporation | 75.75 Million USD | 98.821% |
| Vynleads, Inc. | 36.4 Thousand USD | -2352.96% |